Tyrvaya 0.03 MG nasal spray 4.2ML

Ended Awarded Last action

Contract number
SPE2DR26F91WM
Awardee
Awarding agency
Obligated
$26,481

Award facts

Contract value 100% obligated
$26,481.26 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a $26,481.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tyrvaya 0.03 mg nasal spray (4.2 ml) on January 7, 2026, with an ultimate completion date of January 8, 2026. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. This delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 million through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.

Tyrvaya is a prescription nasal spray treatment for dry eye disease, indicating this procurement supports the medical needs of military personnel and veteran healthcare systems. AmerisourceBergen Drug Corp functions as a critical vendor within the federal pharmaceutical supply chain, leveraging its comprehensive distribution capabilities to fulfill diverse medical product requirements across multiple therapeutic domains. The competitively awarded status and firm fixed-price structure align with standard DLA procurement practices for pharmaceutical commodities delivered through its established prime vendor contracts, ensuring cost certainty and efficient supply chain management for military treatment facilities.

Quick answers

Who was awarded contract SPE2DR26F91WM?

SPE2DR26F91WM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.

How much is contract SPE2DR26F91WM worth?

The government has obligated $26,481 on SPE2DR26F91WM.

Is contract SPE2DR26F91WM an order under another contract?

Yes. SPE2DR26F91WM is a delivery order under SPE2DR25D2103, an indefinite delivery contract.

Was contract SPE2DR26F91WM competed?

The extent of competition for SPE2DR26F91WM was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award